Fundraising Fox

BioQ Pharma

San Francisco, US · California corporation

bioqpharma.com ↗

BioQ Pharma develops invenious, a patented "connect-and-go" delivery platform for infusible medicines that provides all-in-one, pre-filled, ready-to-use delivery systems tailored to specific dosing regimens. The technology targets drugs that are hard to prepare or administer and serves patients, healthcare providers, and payers.

BiotechHealthtechMedical Devices

Founders & leadership

RP
Ron PauliExecutive
JW
Joshua W. KrieselNamed on SEC filing

Board

DT
Daniel TasseBoard director
NW
Norvall William Jasper, Jr.Board director
MJ
Mark J. EhlertBoard director
LK
Llew KeltnerBoard director
CP
Christopher PortmanBoard director
RN
Richard NesbitBoard director

Reported raises · per SEC filings

Form D private placements

$76.1M disclosed across 5 rounds · 2014–2019

▶$4.6MraisedJan 2020 · 15 investors · Pharmaceuticals
Rule 506(b)
Officers, directors & promoters on the filing
  • Joshua W. KrieselExecutive Officer, Director
  • Ron PauliExecutive Officer
  • Norvall William Jasper, Jr.Director
  • Mark J. EhlertDirector
  • Richard NesbitDirector
  • Llew KeltnerDirector
  • Christopher PortmanDirector
  • Daniel TasseDirector
Offering amount
$18.8M
Amount sold
$4.6M
First sale
Dec 2019
Incorporated
Corporation, California
Federal exemptions
06b
Full filing on SEC EDGAR ↗
▶$36.4MraisedNov 2018 · 52 investors · Pharmaceuticals
Rule 506(b)
Officers, directors & promoters on the filing
  • Ron PauliExecutive Officer
  • Norvall William Jasper, Jr.Director
  • Daniel TasseDirector
  • Llew KeltnerDirector
  • Christopher PortmanDirector
  • Richard NesbitDirector
  • Mark J. EhlertDirector
  • Joshua W. KrieselExecutive Officer, Director
Offering amount
$45M
Amount sold
$36.4M
Sales commissions
$102K
Placement agents
Canaccord Genuity Inc.
First sale
Nov 2015
Incorporated
Corporation, California
Federal exemptions
06b
Full filing on SEC EDGAR ↗
▶$6.3MraisedAug 2017 · 2 investors · Pharmaceuticals
Rule 506(b)
Officers, directors & promoters on the filing
  • Joshua W. KrieselExecutive Officer, Director
  • Ron PauliExecutive Officer
  • Daniel TasseDirector
  • Richard NesbitDirector
  • Norvall William Jasper, Jr.Director
  • Mark J. EhlertDirector
  • Christopher PortmanDirector
  • Llew KeltnerDirector
Offering amount
$6.3M
Amount sold
$6.3M
First sale
Aug 2017
Incorporated
Corporation, California
Federal exemptions
06b
Full filing on SEC EDGAR ↗
▶$15MraisedOct 2016 · 1 investors · Pharmaceuticals
Rule 506(b)
Officers, directors & promoters on the filing
  • Ron PauliExecutive Officer
  • Daniel TasseDirector
  • Norvall William Jasper, Jr.Director
  • Mark J. EhlertDirector
  • Joshua W. KrieselExecutive Officer, Director
  • Llew KeltnerDirector
  • Christopher PortmanDirector
  • Richard NesbitDirector
Offering amount
$15M
Amount sold
$15M
Sales commissions
$130K
Placement agents
Trump Securities, LLC
First sale
Oct 2016
Incorporated
Corporation, California
Federal exemptions
06b
Full filing on SEC EDGAR ↗
▶$13.7MraisedNov 2014 · 2 investors · Other Health Care
Rule 506(b)
Officers, directors & promoters on the filing
  • Christopher PortmanDirector
  • Ron PauliExecutive Officer
  • Llew KeltnerDirector
  • Norvall William Jasper, Jr.Director
  • Joshua W. KrieselExecutive Officer, Director
  • Mark J. EhlertDirector
  • Richard NesbitDirector
Offering amount
$13.7M
Amount sold
$13.7M
Sales commissions
$250K
Placement agents
Trump Securities, LLC
First sale
Oct 2014
Incorporated
Corporation, California
Federal exemptions
06b
Full filing on SEC EDGAR ↗

Source: SEC EDGAR Form D. Amounts as filed; amended filings shown once at their latest values.

Competitors · 3

by search overlap
STAQ Pharma13 shared keywordsSTAQ Pharma is a pharmaceutical outsourcing facility that produces sterile injectables and compounded medications for hospitals and healthcare providers. It maintains real-time inventory and regulatory compliance (FDA, USP, ISO, cGMP) to help alleviate drug shortages.
ResQ Pharma13 shared keywordsResQ Pharma is a pharmaceutical company developing LipidRescue (LRT), an investigational lipid-based drug therapy that is pending FDA approval. The company works on biologics development, regulatory affairs, and clinical research for its drug candidate.
IQVIA12 shared keywordsIQVIA provides data, analytics, AI, and technology-driven services for life sciences and healthcare organizations, spanning clinical development, real world evidence generation, and commercial execution. It offers integrated solutions for clinical trials, regulatory and safety compliance, and market analytics, including agentic AI products for commercial and R&D teams.

Companies competing with BioQ Pharma for the same Google search keywords, organic and paid, via search-intersection analysis.

Frequently asked questions

What does BioQ Pharma do?
BioQ Pharma develops invenious, a patented "connect-and-go" delivery platform for infusible medicines that provides all-in-one, pre-filled, ready-to-use delivery systems tailored to specific dosing regimens. The technology targets drugs that are hard to prepare or administer and serves patients, healthcare providers, and payers.
How much funding has BioQ Pharma raised?
BioQ Pharma has disclosed $76.1M raised across 5 rounds.
Where is BioQ Pharma headquartered?
BioQ Pharma is headquartered in San Francisco, US.